Go Pro
→ The world’s least risky AI stock? (From Stansberry Research) (Ad)tc pixel Free AVBP Stock Alerts

ArriVent BioPharma (AVBP) Short Interest Ratio & Short Volume

ArriVent BioPharma logo
$29.68 -0.32 (-1.07%)
As of 10:44 AM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

ArriVent BioPharma Short Interest Overview

As of July 31, 2026, ArriVent BioPharma (AVBP) had a short interest of 8.05 million shares sold short, representing 18.90% of the public float. This marks a 4.97% increase in short interest since the prior report. The short interest ratio (days to cover) is 13.9, meaning it would take 13.9 days of the average trading volume of 515,281 shares to cover all short positions.

Current Short Interest
8,046,475 shares
Previous Short Interest
7,665,375 shares
Change Vs. Previous Month
4.97%
Dollar Volume Sold Short
$239.95 million
Short Interest Ratio
13.9 Days to Cover
Last Record Date
July 31, 2026
Outstanding Shares
46,580,000 shares
Short Percent of Float
18.90%
Today's Trading Volume
86,533 shares
Average Trading Volume
515,281 shares
Today's Volume Vs. Average
17%
Short Selling ArriVent BioPharma?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for ArriVent BioPharma and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

AVBP Short Interest Over Time

AVBP Days to Cover Over Time

AVBP Percentage of Float Shorted Over Time

ArriVent BioPharma Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
7/31/20268,046,475 shares $239.95 million +5.0%18.9%13.92 $29.82
7/15/20267,665,375 shares $252.57 million +0.5%18.0%17.85 $32.95
6/30/20267,624,281 shares $264.87 million -2.9%17.9%9.05 $34.74
6/15/20267,847,671 shares $237.78 million +1.8%18.4%13.12 $30.30
5/29/20267,709,676 shares $233.37 million +5.6%18.1%14.42 $30.27
5/15/20267,299,894 shares $203.45 million +2.7%17.1%22.55 $27.87
4/30/20267,109,751 shares $221.04 million -7.3%16.8%14.3 $31.09
4/15/20267,666,061 shares $225.46 million -1.3%18.0%14.54 $29.41
3/31/20267,763,960 shares $179.11 million +7.4%18.2%17.89 $23.07
3/13/20267,228,395 shares $172.76 million +3.2%20.1%9.33 $23.90
2/27/20267,003,796 shares $160.88 million -0.6%16.4%25.09 $22.97
2/13/20267,046,765 shares $158.27 million -2.4%16.5%11.53 $22.46
1/30/20267,216,603 shares $162.30 million +0.5%21.5%16.7 $22.49
1/15/20267,178,615 shares $157.21 million +2.8%21.4%18.17 $21.90
12/31/20256,985,261 shares $140.54 million +3.5%20.8%14.91 $20.12
12/15/20256,747,370 shares $159.51 million -7.1%20.1%14.76 $23.64
11/28/20257,262,061 shares $166.85 million +1.3%21.6%28.67 $22.98
11/14/20257,169,047 shares $148.33 million +3.5%21.3%19.44 $20.69
10/31/20256,927,026 shares $129.74 million -1.9%21.0%22.65 $18.73
10/15/20257,060,000 shares $145.29 million +4.1%27.5%23 $20.58
9/30/20256,780,000 shares $125.09 million +2.9%24.3%22.3 $18.45
9/15/20256,590,000 shares $124.88 million -3.1%22.1%19.7 $18.95
8/31/20256,800,000 shares $130.02 million +1.5%22.8%19.9 $19.12
8/15/20256,700,000 shares $130.85 million +10.0%26.5%18.7 $19.53
7/31/20256,090,000 shares $118.82 million +5.0%29.3%17.7 $19.51
7/15/20255,800,000 shares $125.40 million +3.0%27.9%17.9 $21.62
6/30/20255,630,000 shares $122.57 million +12.2%27.0%17.6 $21.77
6/15/20255,020,000 shares $116.82 million -12.2%25.9%16.7 $23.27
5/31/20255,720,000 shares $121.26 million +3.6%29.5%23.4 $21.20
5/15/20255,520,000 shares $106.20 million +3.0%28.4%25.5 $19.24
4/30/20255,360,000 shares $113.95 million No Change27.6%26.8 $21.26
4/15/20255,360,000 shares $99.86 million +31.7%27.6%26.4 $18.63
3/31/20254,070,000 shares $75.25 million +10.3%21.0%20.9 $18.49
3/15/20253,690,000 shares $77.49 million -1.1%19.0%21.6 $21.00
2/28/20253,730,000 shares $88.07 million -11.0%19.2%23.4 $23.61
2/15/20254,190,000 shares $111.45 million -3.0%21.8%26.8 $26.60
1/31/20254,320,000 shares $123.29 million +9.1%22.2%27.1 $28.54
1/15/20253,960,000 shares $98.68 million +3.9%20.3%25.8 $24.92
12/31/20243,810,000 shares $101.50 million +13.1%19.5%25.5 $26.64
12/15/20243,370,000 shares $90.05 million +1.8%17.3%21.2 $26.72
How the JPMorgan $8,000 Gold Call Exposed the Biggest Mistake in Most Retirement Accounts (Ad)

JPMorgan has raised its 2026 gold forecast to $6,300, with a credible path to $8,000, and now calls gold a core holding rather than just a crisis hedge. Most Western portfolios still hold less than 1 percent in gold, even as the metal has already topped $5,000 and outpaced the S&P 500 in 2026. Physical gold can be added directly to an existing IRA or 401(k), with no new account, no penalty, and no tax hit.tc pixel

See how to add gold to your IRA or 401k today
11/30/20243,310,000 shares $99.17 million +6.1%17.0%13.3 $29.96
11/15/20243,120,000 shares $84.90 million -11.9%16.1%11.3 $27.21
10/31/20243,540,000 shares $103.86 million +3.8%18.3%12.8 $29.34
10/15/20243,410,000 shares $96.88 million +1.8%17.6%13 $28.41
9/30/20243,350,000 shares $78.73 million +80.1%17.3%13.4 $23.50
9/15/20241,860,000 shares $44.19 million +13.4%9.6%7.9 $23.76
8/31/20241,640,000 shares $43.84 million +0.6%8.5%12.4 $26.73
8/15/20241,630,000 shares $38.89 million -2.4%8.4%19.3 $23.86
7/31/20241,670,000 shares $36.57 million +3.1%8.5%28.2 $21.90
7/15/20241,620,000 shares $31.80 million No Change8.2%26.7 $19.63

AVBP Short Interest - Frequently Asked Questions

Short interest is the volume of ArriVent BioPharma shares that have been sold short but have not yet been closed out or covered. As of July 31st, investors have sold 8,046,475 shares of AVBP short. 18.90% of ArriVent BioPharma's shares are currently sold short. Learn More on ArriVent BioPharma's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AVBP shares currently have a short interest ratio of 13.9. Learn More on ArriVent BioPharma's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 18.90% of ArriVent BioPharma's floating shares are currently sold short.

ArriVent BioPharma saw a increase in short interest in July. As of July 31st, there was short interest totaling 8,046,475 shares, an increase of 5.0% from the previous total of 7,665,375 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

18.90% of ArriVent BioPharma's shares are currently sold short. Here is how the short interest of companies in the industry of "biotechnology" compare to ArriVent BioPharma: Scholar Rock Holding Corporation (16.17%), Grifols, S.A. (0.51%), Travere Therapeutics, Inc. (12.96%), CRISPR Therapeutics AG (20.53%), Dyne Therapeutics, Inc. (12.99%), ACADIA Pharmaceuticals Inc. (8.50%), Celcuity, Inc. (24.28%), Tango Therapeutics, Inc. (32.98%), Viking Therapeutics, Inc. (20.41%), Denali Therapeutics Inc. (12.17%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.50 billion), Invesco QQQ ($50.36 billion), iShares Russell 2000 ETF ($21.20 billion), Western Digital Corporation ($13.40 billion), SPDR S&P Biotech ETF ($11.59 billion), Nebius Group N.V. ($11.46 billion), iShares 20+ Year Treasury Bond ETF ($7.84 billion), iShares iBoxx $ High Yield Corporate Bond ETF ($7.51 billion), iShares Semiconductor ETF ($6.37 billion), and Financial Select Sector SPDR Fund ($6.34 billion). View all of the most shorted stocks.

Short selling AVBP is an investing strategy that aims to generate trading profit from ArriVent BioPharma as its price is falling. AVBP shares are trading down $1.46 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for ArriVent BioPharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of AVBP, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AVBP, twice per month. The most recent reporting period available is July, 31 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like AVBP:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

Short interest data for NASDAQ:AVBP is sourced from the Financial Industry Regulatory Authority (FINRA), with the most recent report published on 8/11/2026. FINRA publishes updated short interest twice a month.
From Our Partners
American retirees will miss THIS. Big Banks just moved in.
Central banks spent nearly $130 billion on physical gold last year, on top of $145 billion the year before. Q1...
Cedar Gold Group | Sponsoredtc pixel
The options guide that actually starts at the beginning
Most options educators jump straight into Greeks, spreads, and implied volatility - losing beginners before th...
Base Camp Trading | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
They didn't warn anyone in 1971. This time someone is warning you.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Buffett's Final Warning: "The Dollar Is Going to Hell"
In 2025, the dollar lost 12% in value. Real inflation hit 5%+. 12% + 5% = 17% purchasing power gone. And it's ...
Decentralized Masters | Sponsoredtc pixel
After KDA, PRE, and OCEAN—this is the one
17,556% on KDA. Here's what I'm buying now. It's a coin under $1.00 that most investors have never heard of...
Crypto 101 Media | Sponsoredtc pixel
How the JPMorgan $8,000 Gold Call Exposed the Biggest Mistake in Most Retirement Accounts
JPMorgan has raised its 2026 gold forecast to $6,300, with a credible path to $8,000, and now calls gold a cor...
Golden Crest Metals | Sponsoredtc pixel
Man who Predicted Trump 2016 Win: “Prepare for Mid-Term Meltdown”
In 2016, major election models gave Hillary Clinton a 99% chance of winning - but former CIA and Pentagon advi...
Paradigm Press | Sponsoredtc pixel